Skip to main content
. 2025 Dec 16;17:7. doi: 10.1038/s41467-025-66334-2

Table 2.

Distribution of clinical and healthcare characteristics of patients diagnosed with lung cancer between 2012 and 2018, by stage at diagnosis

Stage I Stage II Stage III Stage IV Early (Stages I or II) Advanced (Stages III or IV) Missing All patients
Lung cancer patients n % n % n % n % % % n % p-valuea N %
Number of physical morbidities <0.01
0 238 24.8 111 23.0 418 32.0 1,231 36.6 24.2 35.3 235 32.8 2233 32.7
1 263 27.4 140 29.0 383 29.3 1,012 30.1 28.0 29.9 219 30.6 2017 29.5
2 199 20.8 114 23.7 266 20.4 641 19.0 21.7 19.4 150 20.9 1370 20.1
3+ 259 27.0 117 24.3 239 18.3 481 14.3 26.1 15.4 112 15.6 1208 17.7
Number of mental health morbidities <0.01
0 641 66.8 344 71.4 918 70.3 2,523 75.0 68.4 73.7 520 72.6 4,946 72.4
1 169 17.6 85 17.6 258 19.8 644 19.1 17.6 19.3 155 21.6 1,311 19.2
2+ 149 15.5 53 11.0 130 10.0 198 5.9 14.0 7.0 41 5.7 571 8.4
Number of GP consultations 30 days to 2 years prior to cancer diagnosis <0.01
0-9 65 6.8 34 7.1 139 10.6 436 13.0 6.9 12.3 55 7.7 729 10.7
10-19 318 33.2 203 42.1 602 46.1 1468 43.6 36.2 44.3 249 34.8 2840 41.6
20+ 576 60.1 245 50.8 565 43.3 1461 43.4 57.0 43.4 412 57.5 3259 47.7
Haemoptysis 0.11
No 930 97.0 461 95.6 1260 96.5 3286 97.7 96.5 97.3 691 96.5 6628 97.1
Yes 29 3.0 21 4.4 46 3.5 79 2.3 3.5 2.7 25 3.5 200 2.9
Cough or Dyspnoea <0.01
No 357 37.2 189 39.2 568 43.5 1665 49.5 37.9 47.8 312 43.6 3091 45.3
Yes 602 62.8 293 60.8 738 56.5 1700 50.5 62.1 52.2 404 56.4 3737 54.7
Fatigue or Weight loss 0.11
No 846 88.2 422 87.6 1156 88.5 3024 89.9 88.0 89.5 641 89.5 6089 89.2
Yes 113 11.8 60 12.4 150 11.5 341 10.1 12.0 10.5 75 10.5 739 10.8
Anaemia (blood test confirmed) 0.06
No 715 74.6 373 77.4 1007 77.1 2630 78.2 75.5 77.9 452 63.1 5177 75.8
Yes 244 25.4 109 22.6 299 22.9 735 21.8 24.5 22.1 264 36.9 1651 24.2
Total by stage 959 14 482 7.1 1306 19.1 3365 49.3 21.1 68.4 716 10.5 6828 100.0

aPearson’s Chi-squared test (two-sided), limiting to those with complete stage information, was used to test for an association between each listed characteristic and stage at diagnosis (p = <0.05).